- Home
- NRDY vs ANVS Comparison
NRDY vs ANVS Comparison
Compare NRDY & ANVS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | NRDY | ANVS |
|---|---|---|
| Founded | 2007 | 2008 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Computer Software: Prepackaged Software | Biotechnology: Pharmaceutical Preparations |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 102.7M | 111.3M |
| IPO Year | 2020 | 2019 |
Fundamental Metrics
Financial Performance| Metric | NRDY | ANVS |
|---|---|---|
| Price | $0.80 | $2.03 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 1 | 2 |
| Target Price | $1.00 | ★ $13.50 |
| AVG Volume (30 Days) | ★ 829.4K | 359.7K |
| Earning Date | 05-07-2026 | 03-16-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 13.16 | ★ 39.39 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $6.22 | N/A |
| Revenue Next Year | $8.64 | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.77 | $1.11 |
| 52 Week High | $1.90 | $5.50 |
Technical Indicators
Market Signals| Indicator | NRDY | ANVS |
|---|---|---|
| Relative Strength Index (RSI) | 35.57 | 33.25 |
| Support Level | $0.78 | $1.97 |
| Resistance Level | $0.99 | $2.99 |
| Average True Range (ATR) | 0.06 | 0.22 |
| MACD | -0.00 | -0.05 |
| Stochastic Oscillator | 14.06 | 1.89 |
Price Performance
Historical ComparisonAbout NRDY Nerdy Inc.
Nerdy Inc operate a next-generation live tutoring and intervention platform that leverages the power of human expertise with Developed artificial intelligence (AI) to personalize learning, accelerate student achievement, and empower educators. The company's proprietary platform leverages technology, including AI, to connect learners with instructors across a wide range of subjects and formats, including subscription-based learning, one-on-one instruction, small group tutoring, large-format classes, and assessments. Its flagship business operates under the Varsity Tutors brand. The company's offerings are available directly to students and consumers, as well as through schools and other institutions.
About ANVS Annovis Bio Inc.
Annovis Bio Inc is a clinical-stage pharmaceutical company focused on developing and commercializing drugs for the treatment of Parkinson's and Alzheimer's diseases and other neurodegenerative diseases. The pipeline products of the company consists of: Buntanetap for chronic neurodegeneration - including AD and PD; ANVS405 for acute neurodegeneration; and ANVS301 for AD.